Related Experiment Videos
Hypoglycemic activity of olive leaf
M Gonzalez1, A Zarzuelo, M J Gamez
1Departamento de Farmacologia, Facultad de Farmacia, Universidad de Granada, Spain.
Planta Medica
|December 1, 1992
Summary
Olive leaf extract shows significant hypoglycemic activity, peaking in winter. The compound oleuropeoside is identified as a key hypoglycemic agent, demonstrating antidiabetic effects in animal models.
Area of Science:
- Pharmacology and Phytochemistry
- Metabolic Disorders Research
Background:
- Olive leaf (Olea europaea) is traditionally recognized for its health benefits.
- Understanding the specific bioactive compounds and their mechanisms is crucial for therapeutic development.
Purpose of the Study:
- To investigate the hypoglycemic (blood sugar-lowering) activity of olive leaf extracts.
- To identify specific compounds responsible for this activity and elucidate their antidiabetic mechanisms.
Main Methods:
- Collection and extraction of olive leaf samples during different seasons.
- Assay of hypoglycemic activity in extracts.
- Identification and isolation of active compounds, specifically oleuropeoside.
- Evaluation of antidiabetic activity of oleuropeoside in animal models with induced diabetes.
Main Results:
- Maximum hypoglycemic activity was observed in olive leaf samples collected during winter, particularly in February.
- Oleuropeoside was identified as a key compound responsible for the hypoglycemic effect, showing significant activity at 16 mg/kg.
- Oleuropeoside demonstrated notable antidiabetic activity in animals with alloxan-induced diabetes.
Conclusions:
- Olive leaf, especially when harvested in winter, possesses significant hypoglycemic properties.
- Oleuropeoside is a potent hypoglycemic and antidiabetic compound found in olive leaf.
- The antidiabetic action of oleuropeoside likely involves enhancing insulin release and improving peripheral glucose uptake.